BioSpace News Archive

Movano Inc . (NASDAQ:MOVE), a health technology company designing devices that empower individuals to optimize their health to help prevent and better manage chronic diseases, today announced that it will report first quarter 2021 financial and operating results on Thursday, May 13, 2021. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 2:00 p.m. PDT (5:00 p.m. EDT).

Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, announced that it has filed and obtained a receipt for a final base shelf prospectus with the securities regulatory authorities in each of the provinces of Canada.

KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today announced receipt of a regulatory milestone payment of $10 million for the FDA approval of AZSTARYS™ in accordance with the recently amended definitive collaboration and license agreement with Commave Therapeutics,

Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. is moving ahead with advancing its efforts with Ribera Solutions Conect2Med platform with Oncology Pharma exclusivity for oncology, including drug development, clinical trials, personalized oncology and therapeutics.

Dewpoint Therapeutics , the biomolecular condensates company, today announced the appointment of Isaac Klein, M.D., Ph.D., as Chief Scientific Officer, effective May 3, 2021 .

Biosimilars Canada, a national association representing Canada’s biosimilar medicines industry, congratulated the Government of New Brunswick for implementing a biosimilar “switching” or transitioning policy to expand the use of biosimilar medicines under the province’s public drug plans.

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX) (Frankfurt:D2EP) (“Phyto Extractions™" or the “Company) is pleased to announce that it is now producing cannabis shatter products for the Canadian market after wholly-owned subsidiary Adastra Labs Inc.'s commissioning of new hydrocarbon extraction equipment ahead of schedule.

nanoMesh™ LLC, a subsidiary of Exogenesis Corporation, announced today that it has successfully initiated First-In-Man implantation of its proprietary soft tissue repair device, Exogenesis nanoMesh™

IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, announced that its Board of Directors has appointed Will Martin as President and Chief Executive Officer of the Company.

Ainos, Inc., f/k/a Amarillo Biosciences, Inc.(OTCBB:AMAR), a company engaged in the discovery and development of pharmaceutical and biotech products, announced today that it has consummated the transaction pursuant to that certain Securities Purchase Agreement dated December 24, 2020 with a strategic investor, Ainos, Inc., a Cayman Islands corporation